Delivery Order SPE2DB20D1109-SPE2DB25FP25P
- Not listed
- The Defense Logistics Agency awarded a $4,782.46 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location for this pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,854.05 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Levorphanol Tablets 2mg, a controlled pharmaceutical product used in pain management. This firm fixed-price delivery order, valued at $8,422.31, was awarded without set-aside designation through competitive procurement and is scheduled for completion by June 25, 2025. The place of performance is AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Levorphanol Tablets 2mg with a ceiling value of $10,969.48 and a completion date of September 30, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,557.66 firm fixed-price contract is for the delivery of Levorphanol Tablets 2mg, a specialty medication, with a performance period through May 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Levorphanol Tablets 2mg, valued at $3,879.10 under a firm fixed-price contract. This is a non-set-aside award issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of 2 mg levorphanol tablets. The contract has a ceiling value of $3,534.93 and an ultimate completion date of March 24, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP25PDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,071.22 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) under a firm fixed-price contract. The delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and related medical commodities. The DLA Troop Support Medical procurement demonstrates the agency's reliance on qualified pharmaceutical distributors to maintain consistent medication supply chains for military and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/18/25 |